Xencor, Inc Operating Expenses
Xencor, Inc (XNCR) reported Operating Expenses of $88.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- Xencor, Inc operating expenses for the quarter ending 2026-06-30 was $88.29M, a 14.99% increase year-over-year.
- Xencor, Inc operating expenses for the quarter ending 2026-03-31 was $82.38M, a 8.51% increase year-over-year.
- Xencor, Inc operating expenses for the quarter ending 2025-12-31 was $81.86M, a 24.09% increase year-over-year.
- Xencor, Inc operating expenses for the quarter ending 2025-09-30 was $68.52M, a 6.13% decline year-over-year.
- Xencor, Inc operating expenses for fiscal 2025 was $303.08M, a 4.91% increase from fiscal 2024.
- Xencor, Inc operating expenses for fiscal 2024 was $288.90M, a 5.89% decline from fiscal 2023.
- Xencor, Inc operating expenses for fiscal 2023 was $306.98M, a 24.26% increase from fiscal 2022.
- Xencor, Inc operating expenses for fiscal 2022 was $247.05M, a 6.79% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $88.29M 10-Q · filed 2026-08-05 | $170.67M 10-Q · filed 2026-08-05 | $252.53M derived: sum of 3 quarters · filed 2026-08-05 | $321.05M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $82.38M 10-Q · filed 2026-05-06 | $164.24M derived: sum of 2 quarters · filed 2026-05-06 | $232.76M derived: sum of 3 quarters · filed 2026-05-06 | $309.54M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $81.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $150.38M derived: sum of 2 quarters · filed 2026-02-25 | $227.16M derived: sum of 3 quarters · filed 2026-08-05 | $303.08M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $68.52M 10-Q · filed 2025-11-05 | $145.30M derived: sum of 2 quarters · filed 2026-08-05 | $221.21M 10-Q · filed 2025-11-05 | $287.18M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $76.78M 10-Q · filed 2026-08-05 | $152.69M 10-Q · filed 2026-08-05 | $218.67M derived: sum of 3 quarters · filed 2026-08-05 | $291.66M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $75.92M 10-Q · filed 2026-05-06 | $141.89M derived: sum of 2 quarters · filed 2026-05-06 | $214.88M derived: sum of 3 quarters · filed 2026-05-06 | $294.16M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $65.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $138.96M derived: sum of 2 quarters · filed 2026-02-25 | $218.24M derived: sum of 3 quarters · filed 2026-02-25 | $288.90M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $72.99M 10-Q · filed 2025-11-05 | $152.27M derived: sum of 2 quarters · filed 2025-11-05 | $222.93M 10-Q · filed 2025-11-05 | $301.25M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | $79.28M 10-Q · filed 2025-08-06 | $149.94M 10-Q · filed 2025-08-06 | $228.25M derived: sum of 3 quarters · filed 2026-02-25 | $305.69M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | $70.66M 10-Q · filed 2025-05-07 | $148.98M derived: sum of 2 quarters · filed 2026-02-25 | $226.41M derived: sum of 3 quarters · filed 2026-02-25 | $297.93M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $78.32M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25 | $155.75M derived: sum of 2 quarters · filed 2026-02-25 | $227.27M derived: sum of 3 quarters · filed 2026-02-25 | $306.98M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $77.43M 10-Q/A · filed 2025-02-24 | $77.43M 10-Q · filed 2023-11-08 | $148.95M derived: sum of 2 quarters · filed 2025-02-24 | $228.66M 10-Q/A · filed 2025-02-24 | $227.28M 10-Q · filed 2023-11-08 | $292.86M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $71.52M 10-Q/A · filed 2025-02-24 | $151.22M 10-Q/A · filed 2025-02-24 | $149.85M 10-Q · filed 2023-08-03 | $215.43M derived: sum of 3 quarters · filed 2025-02-27 | $281.08M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $79.71M 10-Q/A · filed 2025-02-24 | $78.33M 10-Q · filed 2023-05-08 | $143.91M derived: sum of 2 quarters · filed 2025-02-27 | $209.56M derived: sum of 3 quarters · filed 2025-02-27 | $267.73M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $64.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $129.85M derived: sum of 2 quarters · filed 2025-02-27 | $188.03M derived: sum of 3 quarters · filed 2025-02-27 | $247.05M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $65.65M 10-Q · filed 2023-11-08 | $123.82M derived: sum of 2 quarters · filed 2023-11-08 | $182.85M 10-Q · filed 2023-11-08 | $245.21M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-06-30 | $58.17M 10-Q · filed 2023-08-03 | $117.20M 10-Q · filed 2023-08-03 | $179.57M derived: sum of 3 quarters · filed 2025-02-24 | $240.55M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-03-31 | $59.03M 10-Q · filed 2023-05-08 | $121.39M derived: sum of 2 quarters · filed 2025-02-24 | $182.38M derived: sum of 3 quarters · filed 2025-02-24 | $240.74M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2021-12-31 | $62.36M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | $123.35M derived: sum of 2 quarters · filed 2025-02-24 | $181.71M derived: sum of 3 quarters · filed 2025-02-24 | $231.34M 10-K/A · filed 2025-02-24 | |||
| 2021-09-30 | $60.98M 10-Q · filed 2022-11-07 | $119.34M derived: sum of 2 quarters · filed 2022-11-07 | $168.98M 10-Q · filed 2022-11-07 | $224.53M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-06-30 | $58.36M 10-Q · filed 2022-08-03 | $108.00M 10-Q · filed 2022-08-03 | $163.55M derived: sum of 3 quarters · filed 2023-02-27 | $215.64M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-03-31 | $49.64M 10-Q · filed 2022-05-05 | $105.19M derived: sum of 2 quarters · filed 2023-02-27 | $157.28M derived: sum of 3 quarters · filed 2023-02-27 | $207.97M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2020-12-31 | $55.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $107.64M derived: sum of 2 quarters · filed 2023-02-27 | $158.33M derived: sum of 3 quarters · filed 2023-02-27 | $199.49M 10-K · filed 2023-02-27 | |||
| 2020-09-30 | $52.09M 10-Q · filed 2021-11-08 | $102.78M derived: sum of 2 quarters · filed 2021-11-08 | $143.94M 10-Q · filed 2021-11-08 | $178.03M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $50.69M 10-Q · filed 2021-08-04 | $91.85M 10-Q · filed 2021-08-04 | $125.94M derived: sum of 3 quarters · filed 2022-02-24 | $161.98M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $41.16M 10-Q · filed 2021-05-05 | $75.25M derived: sum of 2 quarters · filed 2022-02-24 | $111.29M derived: sum of 3 quarters · filed 2022-02-24 | $150.34M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $34.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $70.13M derived: sum of 2 quarters · filed 2022-02-24 | $109.18M derived: sum of 3 quarters · filed 2022-02-24 | $142.88M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $36.04M 10-Q · filed 2020-11-06 | $75.09M derived: sum of 2 quarters · filed 2020-11-06 | $108.79M 10-Q · filed 2020-11-06 | $141.44M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $39.06M 10-Q · filed 2020-08-05 | $72.75M 10-Q · filed 2020-08-05 | $105.40M derived: sum of 3 quarters · filed 2021-02-24 | $133.79M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $33.70M 10-Q · filed 2020-05-08 | $66.34M derived: sum of 2 quarters · filed 2021-02-24 | $94.73M derived: sum of 3 quarters · filed 2021-02-24 | $123.02M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $32.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $61.03M derived: sum of 2 quarters · filed 2021-02-24 | $89.33M derived: sum of 3 quarters · filed 2021-02-24 | $119.97M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $28.39M 10-Q · filed 2019-11-05 | $56.68M derived: sum of 2 quarters · filed 2019-11-05 | $87.33M 10-Q · filed 2019-11-05 | $112.15M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $28.29M 10-Q · filed 2019-08-07 | $58.94M 10-Q · filed 2019-08-07 | $83.76M derived: sum of 3 quarters · filed 2020-02-25 | $107.34M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $30.65M 10-Q · filed 2019-05-09 | $55.47M derived: sum of 2 quarters · filed 2020-02-25 | $79.05M derived: sum of 3 quarters · filed 2020-02-25 | $100.06M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $24.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $48.40M derived: sum of 2 quarters · filed 2020-02-25 | $69.41M derived: sum of 3 quarters · filed 2020-02-25 | $89.27M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $23.58M 10-Q · filed 2018-11-05 | $44.59M derived: sum of 2 quarters · filed 2018-11-05 | $64.45M 10-Q · filed 2018-11-05 | $80.92M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $21.01M 10-Q · filed 2018-08-07 | $40.87M 10-Q · filed 2018-08-07 | $57.34M derived: sum of 3 quarters · filed 2019-02-26 | $74.41M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $19.86M 10-Q · filed 2018-05-07 | $36.33M derived: sum of 2 quarters · filed 2019-02-26 | $53.40M derived: sum of 3 quarters · filed 2019-02-26 | $70.85M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $16.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $33.54M derived: sum of 2 quarters · filed 2019-02-26 | $50.99M derived: sum of 3 quarters · filed 2019-02-26 | $64.98M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $17.08M 10-Q · filed 2017-11-08 | $34.53M derived: sum of 2 quarters · filed 2017-11-08 | $48.51M 10-Q · filed 2017-11-08 | $62.83M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | $17.45M 10-Q · filed 2017-08-07 | $31.44M 10-Q · filed 2017-08-07 | $45.75M derived: sum of 3 quarters · filed 2018-02-28 | $59.57M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | $13.98M 10-Q · filed 2017-05-10 | $28.30M derived: sum of 2 quarters · filed 2018-02-28 | $42.12M derived: sum of 3 quarters · filed 2018-02-28 | $52.12M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | $14.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $28.13M derived: sum of 2 quarters · filed 2018-02-28 | $38.13M derived: sum of 3 quarters · filed 2018-02-28 | $46.10M 10-K · filed 2018-02-28 | |||
| 2015-09-30 | $13.81M 10-Q · filed 2016-11-02 | $23.82M derived: sum of 2 quarters · filed 2016-11-02 | $31.78M 10-Q · filed 2016-11-02 | $38.80M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $10.00M 10-Q · filed 2016-08-03 | $17.97M 10-Q · filed 2016-08-03 | $24.98M derived: sum of 3 quarters · filed 2017-03-01 | $32.12M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $7.97M 10-Q · filed 2016-05-02 | $14.98M derived: sum of 2 quarters · filed 2017-03-01 | $22.12M derived: sum of 3 quarters · filed 2017-03-01 | $28.00M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $7.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $14.15M derived: sum of 2 quarters · filed 2017-03-01 | $20.03M derived: sum of 3 quarters · filed 2017-03-01 | $25.98M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $7.13M 10-Q · filed 2015-11-04 | $13.01M derived: sum of 2 quarters · filed 2015-11-04 | $18.96M 10-Q · filed 2015-11-04 | $24.42M derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2014-06-30 | $5.88M 10-Q · filed 2015-08-05 | $11.83M 10-Q · filed 2015-08-05 | $17.28M derived: sum of 3 quarters · filed 2016-03-08 | $22.29M derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2014-03-31 | $5.95M 10-Q · filed 2015-05-05 | $11.40M derived: sum of 2 quarters · filed 2016-03-08 | $16.41M derived: sum of 3 quarters · filed 2016-03-08 | $21.34M derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2013-12-31 | $5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $10.46M derived: sum of 2 quarters · filed 2016-03-08 | $15.39M derived: sum of 3 quarters · filed 2016-03-08 | $20.69M 10-K · filed 2016-03-08 | |||
| 2013-09-30 | $5.00M 10-Q · filed 2014-11-10 | $9.93M derived: sum of 2 quarters · filed 2014-11-10 | $15.24M 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | $4.93M 10-Q · filed 2014-08-01 | $10.23M 10-Q · filed 2014-08-01 | |||||
| 2013-03-31 | $5.31M 10-Q · filed 2014-05-15 | ||||||
| 2012-12-31 | $15.75M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |